Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 207,637 | 98,776 | 24,948 | 120,229 | 178,660 |
| Receivables | 6,271 | 3,683 | N/A | N/A | N/A |
| Inventories | 6,013 | 8,408 | 13,639 | N/A | N/A |
| TOTAL | $228,876 | $119,002 | $47,768 | $130,777 | $189,049 |
| Non-Current Assets | |||||
| PPE Net | 44,456 | 42,252 | 94,028 | 93,814 | 50,558 |
| Intangibles | 120 | 120 | 10,708 | 120 | 0 |
| Other Non-Current Assets | 3,719 | 1,516 | 1,953 | 979 | 1,293 |
| TOTAL | $48,295 | $43,888 | $106,689 | $94,913 | $51,851 |
| Total Assets | $277,171 | $162,890 | $154,457 | $225,690 | $240,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,820 | 2,350 | N/A | N/A |
| Accounts payable and accrued liabilities | 8,114 | 4,546 | 3,782 | 8,068 | 13,282 |
| Accrued Expenses | 22,598 | 10,667 | 12,482 | 9,680 | 7,945 |
| TOTAL | $30,837 | $18,307 | $18,884 | $18,180 | $21,716 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 4,667 | 6,561 | N/A | N/A |
| Other Non-Current Liabilities | 1,184 | 358 | 23,487 | 328 | 467 |
| TOTAL | $1,184 | $5,025 | $30,048 | $328 | $467 |
| Total Liabilities | $32,021 | $23,332 | $48,932 | $18,508 | $22,183 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,405 | 6,435 | 26 | 3 | 533,929 |
| Common Shares | 13 | 4 | N/A | 12 | 16 |
| Retained earnings | -854,715 | -730,694 | -600,658 | -470,038 | -359,820 |
| Other shareholders' equity | -289 | -255 | -232 | -167 | -92 |
| TOTAL | $245,150 | $139,558 | $105,525 | $207,182 | $218,717 |
| Total Liabilities And Equity | $277,171 | $162,890 | $154,457 | $225,690 | $240,900 |